DoKaSch, All Nippon sign deal for temperature-controlled transports

DoKaSch Temperature Solutions will now supply its Opticooler containers to ANA's PRIO PHARMA, a pharmaceutical-specific product, and PRIO TEMP, a temperature-controlled product for non-pharmaceuticals.

DoKaSch, All Nippon sign deal for temperature-controlled transports
X
Listen to this Article

All Nippon Airways (ANA), Japan's largest airline, and DoKaSch Temperature Solutions have signed a Master Rental agreement under which the German expert in active temperature-controlled packaging solutions will now supply its Opticooler containers to ANA's PRIO PHARMA, a pharmaceutical-specific product, and PRIO TEMP, a temperature-controlled product for non-pharmaceuticals.

By combining ANA's extensive global network with the Opticooler's exceptional reliability and safety, Japan's rapidly expanding pharma and biotech industries receive more crucial and life-saving access to secure cold chains.

Dai Yuasa, Vice President of Global Marketing, Cargo Marketing & Services, All Nippon Airways said, “Securing cold chains are becoming increasingly relevant as Japan's pharma and biotech industry is growing strong. By introducing the active temperature-controlled Opticooler and with very high level of reliability and safety, we would like to enhance our service level to meet our valued customers' increasing demand to secure cold chains.”

ANA, founded in 1952, is Japan's sole combination airline, flying both passenger and cargo aircraft on global flights to over 90 airports from its hubs at Narita and Haneda. ANA has been strengthening its pharmaceutical transport and began offering PRIO PHARMA in 2012, while being the first Japanese airline to receive IATA CEIV accreditation in 2017.

The MRA now provides access to DoKaSch TS's globally available container fleet. The temperature-controlled packaging solution is available in two sizes: as Opticooler RAP, providing space for five euro pallets and as RKN for one pallet. Redundant systems for electrification and full air-conditioning enable precise heating and cooling without dry ice. Thus, they are able to transport valuable and sensitive pharmaceuticals while avoiding temperature excursions on an extremely high level and with high independence of outside conditions.

Andreas Seitz, Managing Director of DoKaSch Temperature Solutions said, “Japan's strong pharmaceutical and biotech industry continues to strengthen its relevance in the entire Asia-Pacific region as well as globally. With ANA, we are gaining a strong partner with whom we can further expand our Opticooler network both to serve the increasing demand of secure, fast and responsive cold chains in the important Asian market. Together with the opening of our new service station in Narita and the founding of our own Japan subsidiary, the Master Rental Agreement with ANA is another important step in providing Japanese customers in particular with a reliable option for temperature-controlled transports."

Tags:
Read Full Article
Next Story
Share it